What Drives Attendance And Engagement At Clinical Meetings?

In the world of clinical trials, we treat meeting attendance as the ultimate metric because it is easy to count and report, but true engagement is far more elusive. It isn't found in a flurry of poll responses or performative "interactivity"; rather, it is measured by what happens after the session ends—in the accuracy of site execution and the absence of confused follow-up questions.

Effective meetings are designed, not just scheduled. This means moving away from the habit of stuffing every possible detail into a slide deck and toward cognitive clarity. When coverage is prioritized over comprehension, we inadvertently create a burden of "weight" that sites must carry back to their clinics. To drive real impact, we must front-load the cognitive work: orienting participants by role, respecting their time-zone-fractured attention, and understanding that clarity is always more valuable than completeness. By treating clinical meetings as design challenges rather than logistical hurdles, we can ensure shared time leads to decisive action rather than lingering uncertainty.